Skip to content
Back to Regulated Cyber
Alerts 3 min readCritical

Oracle’s October update delivers 1,295 security patches, including healthcare fixes

Healthcare applications, databases and middleware are in scope. MedTech teams should confirm affected versions and prioritise fixes by exposure and patient-safety impact.

Andrew Chukwu, CISSP

Andrew Chukwu, CISSP, MBA | Editor-in-Chief

Oct 20, 2026

Oracle released its October 2026 Critical Patch Update on 20 October, according to its release announcement, listing 1,295 new security patches addressing vulnerabilities in Oracle code and bundled third-party components.

Oracle warns that attackers have previously succeeded against customers that had not applied available patches. That is a general warning, not confirmation that vulnerabilities in this release are being actively exploited.

Advisory Details
Source Oracle
Advisory Oracle Critical Patch Update Advisory
Date Published20 October 2026
Affected SystemsOracle Health Sciences Information Manager 4.0.0–4.0.3; Oracle Healthcare Data Repository 8.2.0.0–8.2.0.8; Oracle Healthcare Master Person Index 5.0.0.0–5.0.9.7; Oracle Database Server 19.3–19.32, 21.3–21.23 and 23.4.0–23.26.3; E-Business Suite 12.2.3–12.2.15. Also listed: Fusion Middleware, Java SE, MySQL, identity products and supply-chain applications. This is not an exhaustive list; check the advisory for product-specific versions.

These listings do not establish that any particular medical device is affected. Manufacturers must confirm whether affected software is incorporated into, or supports, their products.

Why regulated health-tech teams should act

For medical device manufacturers, separate corporate IT exposure from device software and supporting services. Where a dependency could affect device safety or performance, route the assessment through product security, quality and regulatory processes rather than just infrastructure patch management.

For healthcare delivery organisations, prioritisation should consider clinical availability, data integrity, recovery capability and dependencies between applications. Assess both the consequences of exploitation and the risk of disrupting care during deployment. Record applicability decisions and consider whether findings warrant changes to postmarket risk records or reporting assessments; do not infer a reporting obligation from a product listing alone.

Oracle recommends prompt installation and a monthly security patching cycle.

  1. Map deployments: reconcile asset inventories, SBOMs and supplier records against exact products, versions and installed components.

  2. Prioritise contextually: assess exploit conditions, network reachability, privileges and clinical consequences not just severity scores alone.

  3. Plan controlled deployment: obtain product-specific patch instructions, test critical workflows and recovery, and agree maintenance windows with operational owners.

  4. Document exceptions: assign an owner, interim controls and a review date to deferred fixes.

  5. Close the loop: verify installation and retain evidence. Review earlier advisories where updates were skipped, as Oracle advises.

For MedTech teams, the goal is timely remediation without compromising safe operation. Treat this update as a coordinated security and patient-safety assessment and establish what is affected, address the highest-risk dependencies and verify that essential workflows remain reliable.

References:

Oracle Critical Patch Update Advisory - October 2026

How did this land?

Be the first to react.

Share this alert
LinkedInEmail